Next in pharma 2025: The future is now
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.

Strategic solutions to help you compete in a changing health market — while improving efficiency, managing costs and driving sustainable growth.
Pharmaceutical and life sciences companies are facing increasingly complex challenges globally and must have the scientific, commercial and operational capabilities to compete and deliver value for patients and investors. Our team brings together deep industry insight, hands-on experience and leading tech to help you drive results that last. We work with leaders across the value chain to help spark innovation, fuel growth and move your business forward — every step of the way.
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
Companies are responding with targeted mitigation strategies, while maintaining flexibility as tariff policies continue to evolve.
President Donald Trump is expected to maintain his strong stance on deregulation and prioritize policies that address healthcare access and costs.
PwC’s analysis of US consumers’ attitudes and opinions towards the healthcare system including affordability, adoption of tech-enabled healthcare and trust.
Our team of industry specialists is committed to helping your organization deliver positive outcomes for patients and investors. We can help you reinvent your business model by reshaping portfolios, innovating the patient experience, digitizing the value chain, resetting the cost base and transacting to transform.
We work closely with our clients to drive innovation and advance the development of products to bring to patients. Pharma leaders turn to us to help optimize performance while balancing quality and regulatory requirements. Our advisors have a wealth of industry-based R&D functional expertise and strategic consulting experience with a deep understanding of finance, tax, risk management, compliance, operations and human resources. With our broad capabilities, we help clients confidently evaluate, plan, and deliver on their scientific, clinical, quality and regulatory goals.
Companies are responding with targeted mitigation strategies, while maintaining flexibility as tariff policies continue to evolve.
The health industries quarterly offers insights on accounting and reporting hot topics impacting the industry.
This publication highlights industry-specific factors to be considered and provides guidance on the most pertinent accounting solutions for the pharmaceutical, life sciences and medical device industry.
PwC is excited to be back at Climate Week! Join us September 21-25, 2025.